Athersys Reports Second Quarter 2022 Financial Results and Provides Business Update

Corporate restructuring underway and MASTERS-2 clinical trial prioritizedConference call begins at 4:30 p.m. Eastern time todayCLEVELAND--(BUSINESS WIRE)--$ATHX #ARDS--Athersys, Inc. (NASDAQ: ATHX) announced today its financial results for the three and six months ended June 30, 2022 and provided a business update.S...

Related Keywords

Germany ,Australia ,Taiwan ,Japan ,United States ,United Kingdom ,Texas ,Ohio ,Bankura ,Ankara ,Turkey ,America ,Ellen Gurley ,Dan Camardo ,Kasey Rosado ,Willie Mays ,Sarah Busch ,Maia Hansen ,Business Development Strategy ,Linkedin ,Twitter ,Department Of Defense ,Nasdaq ,Maxim Group ,Armed Forces Radiobiology Research Institute ,Athx Inc ,Facebook ,Uniformed Services University Of The Health Sciences ,World Stroke Congress ,Ankura Consulting Group ,Memorial Hermann Foundation ,Corporate Communications ,Regenerative Medicine Head Of Nonclinical Development ,Technology Enterprise Consortium ,Athersys Inc ,Operational Highlights ,Chief Financial Officer ,Chief Operating Officer ,Growth Conference ,America Securities ,Healthcare Conference ,Executive Vice President ,Regenerative Medicine ,Neuroscience Programs ,Vice President ,Nonclinical Development ,Uniformed Services University ,Health Sciences ,Excellent Outcomes ,Texas Health Science Center ,Medical Technology Enterprise Consortium ,Chief Executive Officer ,Excellent Outcome ,Private Securities Litigation Reform Act ,Nasdaq Listing Rule ,Annual Report ,Tables Follow ,Condensed Consolidated Balance Sheet Data ,Consolidated Statements ,Except Per Share Amounts ,